相关实验视频
Updated: May 8, 2026

08:58
Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis
Published on: March 11, 2017
15.9K
IRS1基因Pro512Ala多态与非酒精性脂肪肝疾病的关联
Asadollah Asadi1, Mitra Rostami2, Radmehr Shafiee3
1University of Mohaghegh Ardabili Faculty of Science Department of Biology Ardabil Iran Department of Biology, Faculty of Science, University of Mohaghegh Ardabili, Ardabil, Iran.
Archives of endocrinology and metabolism
|October 18, 2024
概括
胰岛素受体基质1 (IRS1) rs1801276多态可能会降低非酒精性脂肪肝疾病 (NAFLD) 的风险. 这种基因变异在NAFLD患者中不太常见,这表明它对疾病有保护作用.
科学领域:
- 遗传学 遗传学 是一个
- 肝病学 肝病学是一种肝病学.
- 代谢疾病 代谢疾病
背景情况:
- 非酒精性脂肪肝 (NAFLD) 是一个日益严重的全球健康问题.
- 影响NAFLD易感性的遗传因素尚未完全理解.
- 胰岛素受体基质1 (IRS1) 在涉及代谢疾病的胰岛素信号通路中发挥着关键作用.
研究的目的:
- 为了研究 IRS1 基因 rs1801276 多态性与生检证明的 NAFLD 的风险之间的关联.
- 确定IRS1 rs1801276的特定基因型或基因基因是否与NAFLD有关.
- 探索这种多态性在NAFLD病原体中的潜在保护性或风险转移作用.
主要方法:
- 病例控制研究涉及123名经过活检证明的NAFLD患者和127名健康对照.
- 使用聚合酶链反应-限制片段长度多态 (PCR-RFLP) 技术进行IRS1 rs1801276多态的基因定型.
- 统计分析以比较病例和对照之间的基因型和等位基因频率,并调整潜在的混因素.
主要成果:
- 在两组中都没有观察到 IRS1 rs1801276 变异与哈迪-韦恩伯格平衡的偏差.
- 在NAFLD患者和对照人群之间发现了基因型和等位基因分布的显著差异.
- 与对照组相比,IRS1 rs1801276的"GG+GC"基因型 (P=0.041,OR=0.60) 和"G"等位基因 (P=0.045,OR=0.69) 在NAFLD患者中不太普遍,这表明存在保护性关联.
结论:
- 这项研究提供了第一个证据,表明IRS1rs1801276多态和活检证明的NAFLD之间存在显著的关联.
- 这些发现表明,IRS1 rs1801276多态可能会降低患NAFLD的风险.
- 需要进一步的研究,以充分阐明IRS1基因在NAFLD易感性及其潜在机制中的作用.
相关概念视频
Cell Specific Gene Expression
Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
Liver Physiology
The liver, an essential organ in the human body, performs over 200 vital functions that can be broadly categorized into metabolic, hematological, endocrine regulation, and bile production.
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can also...
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can also...
Diseases of the Liver and Gallbladder
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Cirrhosis II: Pathophysiology
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Chronic Pancreatitis I: Introduction
Chronic pancreatitis is a long-standing, relapsing inflammation of the pancreas, characterized by irreversible damage to the gland. It results in progressive destruction of the pancreatic parenchyma, fibrosis, and eventual loss of both exocrine and endocrine function. The disease may evolve gradually after multiple episodes of acute pancreatitis or develop independently.EtiologyChronic pancreatitis can arise from a variety of causes:Alcohol use is the leading cause, accounting for 70–80% of...
Chronic Pancreatitis II: Pathophysiology
Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...

